Testicular Chromosome Structure and Gene Expression Will Provide an Opportunity to Analyze Male Reproductive Biology and the Processes by Which Sperm Are Formed

02-15-2008

Research and Markets (http://www.researchandmarkets.com/reports/c82923) has announced the addition of “Testicular Chromosome Structure and Gene Expression” to their offering.

The 2005 Workshop, published as volume 1061 of the Annals, focused on testicular cell dynamics and brought an influx of new information into the field of male reproduction. Several laboratories have been actively investigating the endocrine signals between the germ and somatic cells of the testis, revealing previously unknown patterns of cell signalling and cell-to-cell communication in male reproductive tract tissues. Work in this area will provide an opportunity to analyze male reproductive biology and the processes by which sperm are formed in the seminiferous tubule and androgen is synthesized in the interstitium of the testis.

The different levels of organization in the testis, including the stages of spermatogenesis, enzymatic steps of steroidogenesis and the intracellular signalling pathways of hormones, are now more amenable for study and selection of potential targets for drug development. Capitalizing on these developments, the editors of this volume have chosen a roster of chapter contributors that is uniquely suited to stimulate research and development ideas among readers.

Contents:

Preface: Mitchell Eddy and Michael D. Griswold.

Part I: Genomics and Expression Profiling:

1. Towards Understanding the Core Meiotic Transcriptome in Mammals and its Implications for Somatic Cancer: Frédéric Chalmel, Aurélie Lardenois, and Michael Primig.

2. Gene Expression During Development of Fetal and Adult Leydig Cells: Lei Dong, Renshan Ge, Scott A. Jelinsky, Joshua Finger, Daniel S. Johnston, Gregory S. Kopf, Chantal M. Sottas, and Matthew P. Hardy.

3. Identification of Testis-Specific Male Contraceptive Targets: Insights from Transcriptional Profiling of the Cycle of the Rat Seminiferous Epithelium and Purified Testicular Cells: Daniel S. Johnston, Scott A. Jelinsky, Yu Zhi, Joshua N. Finger, Gregory S. Kopf, and William W. Wright.

Part II: Stem Cells and Spermatogonia:

4. Stem Cell Heterogeneity: Actual and Potential Stem Cell Compartments in Mouse Spermatogenesis: Shosei Yoshida, Yo-Ichi Nabeshima, and Toshinori Nakagawa.

5. Culture and Genetic Modification of Mouse Germline Stem Cells: Mito Kanatsu-Shinohara and Takashi Shinohara.

Part III: Regulation of Gene Expression:

6. Regulation and Function of the Rhox5 Homeobox Gene: Zhiying Hu, James A. Maclean, Anjana Bhardwaj, and Miles F. Wilkinson.

7. Non-coding RNAs of the Mammalian Testis: The Meiotic Transcripts Nct1 and 2 Encode piRNAs: Naoko Iguchi, Mingang Xu, Tamaki Hori, and Norman B. Hecht.

8. Promoters, Insulators and Regulation of Testis-specific Gene Transcription: Prabhakara P. Reddi, Craig J. Urekar, Mayuresh M. Abhyankar, and Sandeep A. Ranpura.

Part IV: Somatic Cells of the Testis:

9. Sox8 and Sertoli Cell Function: Claire L. Kennedy, Peter Koopman, Yuji Mishina, and Moira K. O'Bryan.

10. Potential Functions of Retinoic Acid Receptor Alpha in Sertoli Cells and Germ Cells During Spermatogenesis: Timothy J. Doyle, Kirt W. Braun, Derek J. McLean, Raymond W. Wright, Michael D. Griswold, and Kwan Hee Kim.

11. Role of Connexin 43 in Sertoli Cells of Testis: Santhi Sridharan, Ralph Brehm, Martin Bergmann, and Paul S. Cooke.

12. ETV5 is Required for Continuous Spermatogenesis in Adult Mice and May Mediate Blood-Testes Barrier Function and Testicular Immune Privilege: Carla M. K. Morrow, Chris E. Hostetler, Mike D. Griswold, Marie-Claude Hofmann, Kenneth M. Murphy, Paul S. Cooke, and Rex A. Hess.

13. Testicular Morphogenesis: Comparison of In Vivo and In Vitro Models to Study Male Gonadal Development: Kathrin Gassei and Stefan Schlatt.

Part V: Clinical Correlates:

14. From Gonocytes to Testicular Cancer: The Role of Impaired Gonadal Development: Ewa Rajpert-De Meyts and Christina E. Hoei-Hansen.

15. The Role of Dead-End in Germ Cell Tumor Development: Zhu Rui, Chitralekha Bhattacharya, and Angabin Matin.

16. Chromosomes and Expression in Human Testicular Germ Cell Tumors: Insight into Their Cell of Origin and Pathogenesis: Leendert H.J. Looijenga, Ad J. M. Gillis, Hans J. Stoop, Remko Hersmus, and J. Wolter Oosterhuis

For more information visit http://www.researchandmarkets.com/reports/c82923

Contacts
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
Fax: +353 1 4100 980



Related Diseases: Testicular Cancer
 
RECENT NEWS
 
Acute Lymphocytic Leukemia (ALL)
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Cancer drug shows promise against graft vs. host disease
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Acute Myeloid Leukemia (AML)
Genome Sequencer FLX System plus NimbleGen Sequence Capture Arrays Help Unravel the Cryptic Genetic Changes in Hematological Malignancies
Early findings show promise as AS1411 AML study proceeds to higher-dose stage
Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Radiation Therapy for Prostate Cancer Increases Incidence of AML
Amyloidosis
High-Dose Melphalan versus Melphalan plus Dexamethasone for AL Amyloidosis
STEM CELL TRANSPLANTATION PROCEDURE RESULTS IN LONG-TERM SURVIVAL FOR AMYLOIDOSIS PATIENTS
Neurochem receives approvable letter for eprodisate (KIACTA) for treatment of AA amyloidosis
Neurochem, Inc. (NRMX) Receives Approvable Letter for Eprodisate (KIACTA(TM)) for Treatment of AA Amyloidosis; FDA Asks for More Data
Aplastic Anemia
Blood Stem Cells Originate in the Placenta
Stem Cells from a Person's Own Umbilical Cord Effective Treatment For Life-Threatening Blood Disease, Study Data Show
Alexion's Soliris Granted Marketing Approval in Europe for Treatment of All Patients With PNH
Soliris(TM) Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
Decision Fails Patients with Transfusion-Dependent Anemia
Chronic Lymphocytic Leukemia (CLL)
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
New lymphoma therapies targets diverse and difficult cancer
Chronic Myeloid Leukemia (CML)
Activation of LYN kinase is associated with imatinib-resistance in CML patients
CHEMGENEX'S OMACETAXINE DEMONSTRATES ACTIVITY IN CML PATIENTS WHO HAVE FAILED THERAPY WITH MULTIPLE TYROSINE KINASE INHIBITORS
Best and brightest leukemia researchers receive $1-million from Cole Foundation
Microenvironment a main driver of aggressive multi-lineage leukemia disease type
Combination of two novel anti-cancer agents may help fight CML resistant to current therapy
Hodgkin Lymphoma
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Cancer drug shows promise against graft vs. host disease
Hodgkin's lymphoma survivors show higher risk of second cancers
Patients with Lymphoma and CLL Are at Increased Risk of Lung Cancer
Multiple Myeloma
Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma
Does a 10-year 10% Continuous Complete Remission Rate for Myeloma Patients Suggest Cure?
Thalidomide Plus Dexamethasone: Improved Primary Myeloma Therapy
Bone Pain Can Be A Sign Of Myeloma - Patients And Doctors Join Forces To Raise Awareness Of Early Myeloma Diagnosis
Lenalidomide raises clot risk in multiple myeloma patients
Myelodysplastic Syndrome (MDS)
Xanthus Presents Updated Xanafide Phase 2 Data Showing Durable Complete Remissions in Secondary AML
Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine (VNP40101M) in Combination with Cytarabine
ZIOPHARM Presents Positive Data From Phase II Study Of Darinaparsin In Advanced Hematological Malignancies At AACR 2008 Annual Meeting
Scoring system identifies MDS patients who have low-risk disease but a poor prognosis
Seattle Genetics Initiates Phase IIb Clinical Trial of SGN-33 in Combination with Chemotherapy for Acute Myeloid Leukemia
Non-Hodgkin Lymphoma (NHL)
Spicy Pickle(TM) Teams With Leukemia & Lymphoma Society In 'Hike For Discovery' Fundraiser On July 18
Journal of Clinical Oncology Publishes Study of Cephalon Medication TREANDA Plus Rituximab in Relapsed Non-Hodgkin's Lymphoma
Hana Biosciences' Marqibo Receives Orphan Designation From European Commission for the Treatment of Adult Acute Lymphoblastic Leukemia
Aggressive form of lymphoma on the rise: U.S. study
New treatment approach promising for lymphoma patients in the developing world
Testicular Cancer
Single Dose of Carboplatin as Effective as Radiation Therapy for Testicular Cancer
Single Dose of Chemotherapy as Effective as Weeks of Radiation Therapy for Testicular Cancer
Drug avoids radiation for early testicular cancer
Polymorphism Reduces Benefit of Bleomycin in Testicular Cancer
Increased Life Expectancy Seen For Patients With Advanced Colorectal, Ovarian and Testicular Cancer